TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Aug 11, 7:05 AM ET

Shani Eli 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Aug 11, 2022

Insider Transaction Report

Form 4
Period: 2022-08-10
Shani Eli
EVP,Global Marketing&Portfolio
Transactions
  • Exercise/Conversion

    Restricted Share Units

    2022-08-101,5810 total
    Ordinary Shares (1,581 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2022-08-10+1,58119,741 total
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on August 10, 2018, with 1,581 vesting on August 10, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION